Biogen upgrades financial guidance after exceeding expectations in Q2
Halfway through the accounting year, Biogen predicts a higher revenue than previously expected.
BY RITZAU FINANS, TRANSLATED BY CATHERINE BRETT
US firm Biogen has upgraded its guidance for the financial year and now predicts a higher revenue than originally expected, Bloomberg News writes based on the company's Q2 report.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
FDA changes prescribing information for new Alzheimer's drug
For subscribers
Biogen to start shipping new Alzheimer's drug in two weeks
For subscribers
.jpg)
.jpg&w=384&q=75)
